Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (71-80 of 380) with videos related to

Pageof 38
Sort By:
Hematology, Transfusion and Cell Therapy|February 15, 2021
Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experienceMaria Queralt Salas, Alberto Mussetti, Carme Muñóz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RICPere Barba, Jose Luis Piñana, Rodrigo Martino, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
British Journal of Haematology|October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphomaGraham P Collins, Anne N Parker, Christopher Pocock, et al.
Blood Advances|September 8, 2021
Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantationMarta Peña, Maria Queralt Salas, Alberto Mussetti, et al.
Transplantation and Cellular Therapy|March 15, 2023
American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem MeetingShinichiro Okamoto, Minako Iida, Nada Hamad, et al.
Haematologica|March 26, 2003
Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantationLuís Villela, Anna Sureda, Carme Canals, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experienceJose Luis Piñana, David Valcárcel, Rodrigo Martino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantationCharalampia Kyriakou, Carmen Canals, Jürgen Finke, et al.
Haematologica|August 6, 2002
Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic studyJosep F Nomdedéu, Adriana Lasa, Josep Ubeda, et al.
Pageof 38

Showing results (71-80 of 380) with videos related to

Sort By:
Pageof 38
Hematology, Transfusion and Cell Therapy|February 15, 2021
Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experienceMaria Queralt Salas, Alberto Mussetti, Carme Muñóz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RICPere Barba, Jose Luis Piñana, Rodrigo Martino, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
British Journal of Haematology|October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphomaGraham P Collins, Anne N Parker, Christopher Pocock, et al.
Blood Advances|September 8, 2021
Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantationMarta Peña, Maria Queralt Salas, Alberto Mussetti, et al.
Transplantation and Cellular Therapy|March 15, 2023
American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem MeetingShinichiro Okamoto, Minako Iida, Nada Hamad, et al.
Haematologica|March 26, 2003
Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantationLuís Villela, Anna Sureda, Carme Canals, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experienceJose Luis Piñana, David Valcárcel, Rodrigo Martino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantationCharalampia Kyriakou, Carmen Canals, Jürgen Finke, et al.
Haematologica|August 6, 2002
Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic studyJosep F Nomdedéu, Adriana Lasa, Josep Ubeda, et al.
Pageof 38